All the latest news on the marijuana space delivered directly to your inbox.
TheSeedInvestor
Read our Medical Marijuana Compound Report for Free Today!
The next big innovation is unfolding now and it’s already creating a wave of multi-millionaire investors in the process

 
13x13x1 READ MORE
Read the Investors Guide To Newly Emerging Marijuana Markets 
LEARN MORE
600x300
Leafly Hires New CEO Chris Jeffery

As CEO, Chris Jeffery is responsible for Leafly’s vision and strategy as the company expands its operations and product offering around the globe.

13x13x1 READ MORE
600x300
MedReleaf receives license amendment from Health Canada to commence sales at its Bradford Facility

Increases the Company's total current licensed production and sales capacity by 80% to approximately 12,600 kg per year.

13x13x1 READ MORE
600x300
Emblem Receives Health Canada License to Sell Cannabis Extracts

Emblem granted a license from Health Canada for the production of cannabis extracts

13x13x1 READ MORE
600x300
Maricann Enters Into Collaboration Agreement

Maricann and a national provider that services pharmacies across Canada, have entered into a definitive agreement to create a pharmacy services program that enables pharmacists to counsel and appropriately educate patients in relation to medicinal cannabis.

13x13x1 READ MORE
Please see full disclaimers on the TheSeedInvestor.com website applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimerDisclaimer.

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed inv­estment advisor. 
 
32x32x1   32x32x2   32x32x3
TheSeedInvestor.com
9375 E Shea Blvd Ste 100
Scottsdale 85260
info@theseedinvestor.com
 
©2018, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.